Search
Search through the thousands of lawsuits, complaints and recalls on our site.

MasTec Shareholders Impugn Company For GAAP Violations

Report Fraud
Case ID: 3364 | Stocks | 04/13/2006

Several class actions have been filed against infrastructure service provider MasTec, Inc. (NYSE:MTZ) and certain of its officers and directors by stockholders who purchased the company's common stock between May 13, 2003, and April 12, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

The action alleges that the defendants failed to disclose the following: (1) that MasTec was materially inflating its financial results; (2) that it was prematurely recognizing revenue on various contracts; (3) that its practice of improperly recognizing revenue was in violation of Generally Accepted Accounting Principles ("GAAP"); (4) that the company overstated its inventory; (5) that it failed to have adequate reserves for bad debts, inventory, cost overruns, and projected losses on certain projects; and (6) as a result, the company's financial results were materially inflated at all relevant times.

On March 10, 2004, MasTec announced that the filing of its 10-K would be delayed past the March 15th deadline. Shares of MasTec immediately fell $2.00 per share, or 16.75%, to close at $9.94 per share. On March 18, 2004, MasTec further declined $2.31 per share, or 23%, to close at $7.75 per share, when Standard & Poor's Rating Services put the Company's BB credit rating on watch for a downgrade.

On April 13, 2004, MasTec announced its 2003 operating results and disclosed material problems that would result in a restatement of its previously announced financial results. It announced a net loss of $39.7 million ($0.83 per share) on revenue of $873.9 million for the year. Additionally, the company disclosed that during its review and analysis of its annual results, MasTec's management identified a number of matters that impacted current and prior-period operating results. These included additional reserves for bad debts and inventory, cost overruns and projected losses on certain projects, valuation reserves for state deferred tax assets, revenues recognized on various contracts, work in progress and inventory overstatements at a Canadian subsidiary, the closing of Brazilian operations, and the accrual for certain insurance reserves which was complicated by the receivership of a prior insurance carrier, as well as other items. The defendants concluded that these matters required a detailed analysis and evaluation to determine the appropriate accounting treatment.

This news shocked the market-- MasTec shares dropped $1.50 per share, or 15.5%, on April 13, 2004, on unusually large trading volumes.

If you purchased securities issued by MasTec during the applicable period, you may request appointment by the court as a lead plaintiff if you do so by June 14, 2004. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the court must determine that your claim is typical of the claims of other class members, and that you will adequately represent the class. Under certain circumstances, one or more class members may together serve as lead plaintiffs. Your ability to share in any recovery is not affected by the decision whether or not to serve as a lead plaintiff. You may retain any counsel of your choice to serve as you in this action, or you may choose to do nothing, and remain in the class as a silent member.


At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints.

Other Stocks Cases of Interest

Deregulation of the market has done stockholders no favors. Several class actions have been filed against jewelry retailer Friedman's, Inc. Friedman's, Inc. (NYSE: FRM, formerly Nasdaq: FRDM) and certain of its officers and directors by stockholders who purchased the company's common stock between January 26, 2000, through November 17, 2003, and all those who purchased Friedman's shares in its offering on February 11, 2002, for $9.50 per share and its offering on September 18, 2003, for $15.00 per share. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.
 
Financing your retirement can be a very frightening, and dangerous, thing if you don't know what you are doing. A class action has been filed against Salomon Smith Barney, Inc. and certain of its agents on behalf of a group of North Carolina BellSouth retirees who allege that the company gave them faulty financial planning advice in violation of state consumer protection laws.
 
The parties have reached a tentative $21 million settlement in a class action filed against the Morrison Knudsen Savings Plan, the Morrison Knudsen Corporation Employee Stock Ownership Plan, other various corporate defendants, and 29 individual defendants on behalf of all current and former participants of the Savings Plan who held shares of Morrison Knudsen stock in their savings plan accounts on or after July 19, 1994, and all individuals who were participants of the Morrison Knudsen Employee Stock Ownership Plan on or after July 19, 1994. The settlement notice does not indicate a claims deadline— persons eligible to take part in the settlement should contact the attorneys for the class for more information.
 
A class action has been filed against Radiation Therapy Service, Inc., (NASDAQ: RTSX) and certain of its officers and directors by stockholders who purchased the company’s common stock between June 17, 2004 and September 8, 2004. The Company owns, operates and manages treatment centers, focused on providing comprehensive radiation treatment alternatives ranging from conventional external beam radiation to newer, technologically advanced options. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company’s securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.
 
On May 12, 2008, a motion to appoint lead plaintiff and lead counsel was filed.
 
Several class actions have been filed against the officers and directors of biotechnology company Organogenesis, Inc. (formerly AMEX: ORG) by stockholders who purchased the company's common stock between November 15, 1999, and January 30, 2002. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.
 
Become a LawCash Member - FREE!
'Find Money' E-Book
Weekly Email Alerts




privacy policy
YouNewz Beta
IT'S FREE

Report

Report Newz and easily upload your own newzworthy photos from your cell phone or computer to the web.

Share

Quickly share your photos with family, friends, co-workers, or the world with your own Newzpaper.

Read

Instantly find Newz and photos from other YouNewzers and read other YouNewzers Newzpapers.
 
Class Action Lawsuit Center || Product Recall Center || Consumer Complaint Center || About LawCash Link Exchange
Privacy Policy || Legal Policies || Terms & Conditions || Website Advertising Policy || Site Map || Top Lawsuits
LawCash® is a service of nola3, llc
© 2000 - 2008 Copyright. All rights reserved nola3, llc.

[ Home ]
LawCash
login
Justice is a click away.